Co-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, Thailand
10/19/2022 - 09:30 AM
SALT LAKE CITY Oct. 19, 2022 (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting booths this week at IDWeek 2022 in Washington, D.C. , and at Asia Health/Medlab Asia in Bangkok, Thailand .
This year's objectives for IDWeek, held on October 19-23 and live for the first time in 3 years, include updating infectious disease industry professionals on developments in the field, helping to bridge the gap between clinical practice and research, and facilitating advances in the prevention, diagnosis, and treatment of infectious diseases.
The Asia Health/Medlab Asia conference (October 19-21 ) is being held in Thailand for the first time, and is intended to bring together healthcare and laboratory communities to network and do business in what the conference website describes as a virtual one-stop-shop for all healthcare and medical laboratory sourcing needs, with over 40% of the audience being made up of distributors.
The Company's booths will showcase Co-Diagnostics' state-of-the-art CoPrimer™ PCR technology and infectious disease products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform.
Additional details, including registration information, can be found on the conference websites:
https://idweek.org/
https://www.medlabasia.com/asiahealth/en/congress/congress-overview.html
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.
https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-host-booths-at-conferences-in-washington-dc-and-bangkok-thailand-301653314.html
SOURCE Co-Diagnostics
CODX Rankings
#5113 Ranked by Stock Gains
CODX Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Salt Lake City
About CODX
co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are
